Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3207-3213

  Swanson, Steven M ^a   Christov, Konstantin ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Estradiol; Hormonal chemoprevention; Mammary cancer; Progesterone; Rats

Indexed keywords

CARCINOGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; METHYLNITROSOUREA; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER PREVENTION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE FREQUENCY; GENE MUTATION; HISTOPATHOLOGY; INJECTION; LATENT PERIOD; MAMMARY GLAND; MATING; NONHUMAN; NURSING; ONCOGENE H RAS; PREGNANCY; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, RAS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MUTATION; PROGESTERONE; RATS; RATS, INBRED LEW; RECEPTORS, ESTROGEN;

EID: 0043031110     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Going JJ, Anderson TJ, Battersby S and MacIntyre CC: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130: 193-204, 1988.
2. Bresciani F: Ovarian steroid control of cell proliferation in the mammary gland and cancer. In: Basic Actions of Sex Steroids on Target Organs (P. Hubinont, F, Leroy and P. Galand, eds.). Basel: Karger, 1971, pp. 130-159.
3. Welsch CW: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to harles Brenton Huggins. Cancer Res 45: 3415-3443, 1985.
4. Kelsey JL and Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health 17: 47-67, 1996.
5. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG and Yuasa S: Age at first birth and breast cancer risk. Bull. World Health Organ 43: 209-221, 1970.
6. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR and van Zwieten MJ: Biology of disease. Comparative study of human and rat mammary tumorigenesis. Laboratory Investigations 62: 244-278, 1990.
7. Moon RC: Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int J Cancer 4: 312-317, 1969.
8. Dao T, Bock F and Greiner M: Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect of pregnancy and lactation on tumor induction. J Nat Cancer Inst 25: 991-1003, 1960.
9. Grubbs CJ, Peckham JC and McDonough KD: Effect of ovarian hormones on the induction of 1-methyl-l-nitrosourea-induced mammary cancer. Carcinogenesis 4: 495-497, 1983.
10. Grubbs CJ, Farnell DR, Hill DL and McDonough KC: Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst 74: 927-931, 1985.
11. Grubbs CJ, Juliana MM and Whitaker LM: Short-term hormone treatment as a chemopreventive method against mammary cancer initiation in rats. Anticancer Res 8: 113-117, 1988.
12. Huggins C and Yang NC: Induction and extinction of mammary cancer. Science 137: 257-262, 1962.
13. Landau RL, Ehrlich EN and Huggins C: Estradiol benzoate and progesterone in advanced human breast cancer. JAMA 182: 632-636, 1962.
14. Crowley LG and MacDonald I: Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal woman. Cancer 18: 436-446, 1965.
15. Institute of Laboratory Animal Resources (U.S.) Guide for the Care and Use of Laboratory Animals, 7th edition, p. xii, 125. Washington, D.C.: National Academy Press, 1996.
16. Kumar R and Barbacid M: Oncogene detection at the single cell level. Oncogene 3: 647-651, 1988.
17. El-Sohemy A and Archer MC: Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-ras mutations. Carcinogenesis 21: 827-31, 2000.
18. Ruta M, Wolford R, Dhar R, Defeo-Jones D, Ellis RW and Scolnick EM: Nucleotide sequence of the two rat cellular rash genes. Mol Cell Biol 6: 1706-10, 1986.
19. Strauss WT: Preparation of genomic DNA from mammalian tissues. In: Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K, eds.). Vol. 1, New York: John Wiley & Sons, 1998, pp. 2.2.1-2.2.3.
20. Rasmussen SB, Young LJT and Smith GH: Preparing mammary gland whole mounts from mice. In: Methods in Mammary Gland Biology and Breast Cancer Research (Ip MM and Asch BB, eds.). New York: Kluwer, 2000, pp. 75-85.
21. Barbacid M: ras oncogenes: their role in neoplasia. Eur J Clin Invest 20: 225-35, 1990.
22. Huggins C, Grand LC and Brillantes FP: Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature 189: 204-207, 1961.
23. Swanson SM, Whitaker LM, Stockard CR, Myers RB, Oelschlager D, Grizzle WE, Juliana MM and Grubbs CJ: Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer. Anticancer Res 17: 4639-45, 1997.
24. Zhang R, Haag JD and Gould MN: Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res 50: 4286-90, 1990.
25. Preston-Martin S, Pike MC, Ross RK, Jones PA and Henderson BE: Increased cell division as a cause of human cancer. Cancer Res 50: 7415-7421, 1990.
26. Sinha DK and Pazik JE: Tumorigenesis of mammary gland by 7,12-dimethylbenz(a)anthracene during pregnancy: relationship with DNA synthesis. Int J Cancer 27: 807-10, 1981.